B 1 inhomogeneity corrected CEST MRI based on direct saturation removed omega plot model at 5T
Magnetic Resonance in Medicine · 2024
DOI: 10.1002/mrm.30112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Magnetic Resonance in Medicine, 2024. Verfasst von Qiting Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Algorithms, Image Processing, Computer-Assisted, Artifacts. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Scientific and Technological Innovation Talent Training Program of Shenzhen, National Natural Science Foundation of China, Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province.
Abstract (Originalsprache)
Purpose
CEST can image macromolecules/compounds via detecting chemical exchange between labile protons and bulk water. B 1 field inhomogeneity impairs CEST quantification. Conventional B 1 inhomogeneity correction methods depend on interpolation algorithms, B 1 choices, acquisition number or calibration curves, making reliable correction challenging. This study proposed a novel B 1 inhomogeneity correction method based on a direct saturation (DS) removed omega plot model.
Methods
Four healthy volunteers underwent B 1 field mapping and CEST imaging under four nominal B 1 levels of 0.75, 1.0, 1.5, and 2.0 μT at 5T. DS was resolved using a multi‐pool Lorentzian model and removed from respective Z spectrum. Residual spectral signals were used to construct the omega plot as a linear function of 1/, from which corrected signals at nominal B 1 levels were calculated. Routine asymmetry analysis was conducted to quantify amide proton transfer (APT) effect. Its distribution across white matter was compared before and after B 1 inhomogeneity correction and also with the conventional interpolation approach.
Results
B 1 inhomogeneity yielded conspicuous artifact on APT images. Such artifact was mitigated by the proposed method. Homogeneous APT maps were shown with SD consistently smaller than that before B 1 inhomogeneity correction and the interpolation method. Moreover, B 1 inhomogeneity correction from two and four CEST acquisitions yielded similar results, superior over the interpolation method that derived inconsistent APT contrasts among different B 1 choices.
Conclusion
The proposed method enables reliable B 1 inhomogeneity correction from at least two CEST acquisitions, providing an effective way to improve quantitative CEST MRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
- Department of Biomedical Engineering, Chongqing University of Technology, Chongqing, China.
ORCID-Profile: Dong Liang, Hairong Zheng, Yin Wu
Förderung
- Scientific and Technological Innovation Talent Training Program of Shenzhen
- National Natural Science Foundation of China
- Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province
Zitieren
APA
Wu, Q., Gong, P., Liu, S., Li, Y., Liang, D., Zheng, H., & Wu, Y. (2024). B 1 inhomogeneity corrected CEST MRI based on direct saturation removed omega plot model at 5T. Magnetic Resonance in Medicine. https://doi.org/10.1002/mrm.30112
Vancouver
Wu Q, Gong P, Liu S, Li Y, Liang D, Zheng H, et al. B 1 inhomogeneity corrected CEST MRI based on direct saturation removed omega plot model at 5T. Magnetic Resonance in Medicine. 2024. doi:10.1002/mrm.30112
BibTeX
@article{Wu2024,
author = {Wu, Qiting and Gong, Pengcheng and Liu, Shengping and Li, Ye and Liang, Dong and Zheng, Hairong and Wu, Yin},
title = {B 1 inhomogeneity corrected CEST MRI based on direct saturation removed omega plot model at 5T},
journal = {Magnetic Resonance in Medicine},
year = {2024},
doi = {10.1002/mrm.30112}
}
EUVIMED